Clinical High Risk for Psychosis (CHR): Clinical Trials

13 trials for Clinical High Risk for Psychosis (CHR), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 recruiting, 4 not yet recruiting. 10 Not applicable, 2 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable10Recruiting 8, Not yet recruiting 2
Phase 12Not yet recruiting 1, Recruiting 1
Phase 21Recruiting 1
Phase 31Not yet recruiting 1

Follow Clinical High Risk for Psychosis (CHR): new trials by email Literature Review of Clinical High Risk for Psychosis (CHR) trials Research Report on Clinical High Risk for Psychosis (CHR)

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy of Mindfulness in PREventing Progression to Psychosis in Individuals With an Ultra High Risk for Psychosis
MBTP : Mindflulness based training for psychosis - Clinical High Risk for Psychosis (CHR)
Not applicableNot yet recruitingCentre Psychothérapique de Nancy2702029-04-012026-03-25
Stratification and Treatment in Early Psychosis Study - PROMOTE
Cannabidiol (CBD), Placebo - Clinical High Risk for Psychosis (CHR), Clinical High Risk for Psychosis
Phase 3Not yet recruitingUniversity of Oxford5862026-12-012026-10-08
Mobile Thinking Intervention: A Inital Test
Mobile Intervention for Biased Thinking - Schizophrenia, Clinical High Risk for Psychosis (CHR)
Not applicableNot yet recruitingUniversity of Alabama at Birmingham1002026-12-012026-10-13
A Multimodal Imaging Study of Dopamine in Early Psychosis
Methylphenidate (MPH), [11C]raclopride - Clinical High Risk for Psychosis (CHR)
Phase 1Not yet recruitingNew York State Psychiatric Institute1152026-10-012026-07-14
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
Suicide Prevention Intervention, Standard Care (in control arm) - Clinical High Risk for Psychosis (CHR), Suicidal Ideation
Not applicableRecruitingUniversity of California, San Diego1082026-10-012026-10-22
Accelerated Neuromodulation Therapy and Neurocomputational Biomarkers in Individuals at Clinical High Risk for Psychosis
Active Intermittent Theta Burst Stimulation (BEAM-F3 Targeting), Sham Comparator: Sham iTBS - Clinical High Risk for Psychosis (CHR), Psychotic Disorders
Not applicableRecruitingDouglas Mental Health University Institute402026-08-012026-08-28
Digital Dialectical Behavioural Therapy (d-DBT) for Youth at Clinical High Risk (CHR) for Psychosis
d-DBT - Clinical High Risk for Psychosis (CHR)
Not applicableRecruitingCentre for Addiction and Mental Health602026-04-282026-09-09
A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis
MT1988 Low Dose, MT1988 High Dose, Placebo - Clinical High Risk for Psychosis (CHR)
Phase 1 / Phase 2RecruitingMonument Therapeutics Limited1502026-03-032026-06-08
Experience of UHR and PEP Individuals During Mindfulness: a Qualitative Phenomenological Study
Qualitative interview - Clinical High Risk for Psychosis (CHR)
Not applicableRecruitingCentre Psychothérapique de Nancy202026-01-192026-03-30
French Validation of Schizophrenia Proneness Instrument- Child Youth
Psychiatric and psychological diagnostic tests - Clinical High Risk for Psychosis (CHR)
Not applicableRecruitingCentre Psychothérapique de Nancy522025-02-132026-04-24
Interventions for Clinical High Risk Youth in Tunisia
Cognitive training (CT) plus the neuropsychological educational approach to cognitive remediation (NEAR) model and an Enhanced - Treatment as Usual (E-TAU), Enhanced - Treatment as Usual - Clinical High Risk for Psychosis (CHR)
Not applicableRecruitingUniversity of California, Los Angeles542023-09-012025-11-25
Telehealth Cognitive Behavioral Therapy for Youth at Risk for Psychosis
CBT Skills Group for CHR Youth, Individual CBT sessions, CBT Skills Group for Families - Clinical High Risk for Psychosis (CHR)
Not applicableRecruitingIcahn School of Medicine at Mount Sinai722023-07-212026-01-20
Reducing the Duration of Untreated Psychosis in the United States: The Impact of Screening and Systematic Communication
Screening Method (SM), Screening and Communication Method (SCM) - First Episode Psychosis (FEP), Clinical High Risk for Psychosis (CHR)
Not applicableRecruitingIcahn School of Medicine at Mount Sinai9122023-05-012026-09-18

Narrower conditions

Psychotic Disorders (6)  ·  Communication (1)  ·  Prodromal Symptoms (1)  ·  Schizophrenia (1)  ·  Suicidal Ideation (1)  ·  Suicide (1)

Broader conditions

Mental Disorders (7)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (7)  ·  Behavior (2)  ·  Behavioral Symptoms (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Self-Injurious Behavior (1)  ·  Signs and Symptoms (1)

Interventions

Cannabidiol (1)  ·  Cognitive Training (1)  ·  High-Throughput Screening Assays (1)  ·  Mass Screening (1)  ·  Methylphenidate (1)  ·  Models, Biological (1)  ·  Standard of Care (1)

Sponsors

Centre Psychothérapique de Nancy (3)  ·  Icahn School of Medicine at Mount Sinai (2)  ·  Centre for Addiction and Mental Health (1)  ·  Douglas Mental Health University Institute (1)  ·  Monument Therapeutics Limited (1)  ·  New York State Psychiatric Institute (1)  ·  University of Alabama at Birmingham (1)  ·  University of California, Los Angeles (1)  ·  University of California, San Diego (1)  ·  University of Oxford (1)

Countries

United States (5)  ·  Canada (3)  ·  France (3)  ·  Austria (1)  ·  Finland (1)  ·  Germany (1)  ·  Greece (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Spain (1)  ·  Switzerland (1)  ·  Tunisia (1)  ·  United Kingdom (1)

Top investigators

David Benrimoh (1)  ·  Joseph Ventura, Ph.D. (1)  ·  M. Omair Husain, MBBS, MRCPsych (1)  ·  Martha E Shenton, PhD (1)  ·  Philip McGuire, PhD, MD (1)  ·  Scott Woods, M.D. (1)  ·  Vincent Laprevote, PU.PH (1)  ·  Yulia Landa (1)  ·  Yulia Landa, PsyD, MS (1)

Results publications

PMID 41433354

NIH funding

R01MH128330 (1), R01MH130354 (1), R01MH144654 (1), R21MH131319 (1), R34MH128502 (1), U01MH137298 (1), U24MH137171 (1)